CN Stock MarketDetailed Quotes

688202 Shanghai Medicilon Inc.

Watchlist
  • 32.97
  • +0.16+0.49%
Trading May 29 13:03 CST
4.44BMarket Cap-25757P/E (TTM)

About Shanghai Medicilon Inc. Company

The company is a professional biomedical pre-clinical comprehensive research and development service CRO, providing a full range of one-stop new drug research and development services that meet domestic and international application standards for pharmaceutical companies and research institutions around the world. The company's services cover the whole process of pre-clinical drug research, mainly including drug discovery, pharmaceutical research and pre-clinical research. The company is a professional biomedical pre-clinical comprehensive research and development service CRO, providing a full range of one-stop new drug research and development services that meet domestic and international application standards for pharmaceutical companies and research institutions around the world. The company's drug discovery research and development service projects include protein target verification, structural biology, chemical synthesis, compound activity screening and optimization; pharmaceutical research includes research on raw materials and formulation processes, quality standards and stability studies; and pre-clinical research includes pharmacodynamics, pharmacokinetics, and toxicological safety evaluation studies. Corporate honors: AAALAC certification, national pharmaceutical clinical research and development base, NMPA Pharmaceutical Safety Assessment GLP laboratory, life science base, “2022 Continuous Investment Value 'Star' Company”, “2022 Listed Company Enterprise Number 'Investment Elite Award'”, “Golden Horse Award - 2022 Best Pre-clinical CRO/CDMO Company (Mature)”, “3rd Pharmaceutical Innovation World Award 'Top 10 Pharmaceutical Innovation Service Organizations' of the Year”, “2023 Top 20 Chinese Pharmaceutical Companies”, etc. Honors include “2023 China's Top 20 Pharmaceutical CRO Companies”, “Top 10 Most Influential CRO Companies in the 2023 China Biomedical Industry Value List”, “Top 50 Chinese Pharmaceutical Research and Development”, and “2023 Golden Bull Science and Technology Innovation Award”.

Company Profile

Short Name-A美迪西生物医药
Company NameShanghai Medicilon Inc.
Listing DateNov 5, 2019
Issue Price41.50
Shares Offered15.50M share(s)
FoundedFeb 2, 2004
Chairmanjinzhang chen
Legal Representativejinzhang chen
General ManagerCHUN-LIN CHEN
Secretarychao xue
Employees2600
ProvinceShang Hai Shi
Phone021-58591500
Office AddressNo. 585 Chuanda Road, Chuansha New Town, Pudong District, Shanghai
Zip Code201299
Registered AddressBuilding 5, Lane 67, Li Bing Road, China (Shanghai) Pilot Free Trade Zone
Fax021-58596369
EmailIR@medicilon.com.cn
Business License9131000075842961XY
BusinessThe company is a professional biomedical pre-clinical comprehensive R&D service CRO, providing a full range of one-stop new drug research and development services that meet domestic and international application standards for pharmaceutical companies and scientific research institutions around the world. The company's services cover the whole process of pharmaceutical pre-clinical drug research, mainly including drug discovery, pharmaceutical research and preclinical research.

Company Executives

  • Name
  • Position
  • Salary
  • jinzhang chen
  • Chairman,directors
  • --
  • CHUN-LIN CHEN
  • directors,general manager,Core technical personnel
  • 925.00K
  • zhangqing lin
  • directors
  • --
  • jinna cai
  • directors
  • 861.40K
  • guoxing chen
  • directors
  • --
  • jinye xu
  • Independent directors
  • 120.00K
  • weidong lai
  • Independent directors
  • 120.00K
  • dawei ma
  • Independent directors
  • 120.00K
  • chao xue
  • Board Secretary
  • 504.00K
  • nan zhuo
  • Securities affairs representative
  • --
  • xiancheng ceng
  • Chairman of the Supervisory Board,Senior Director of Toxicology Research,Employee supervisors
  • 760.80K
  • weichun jin
  • auditors
  • --
  • binbin liu
  • Head of finance
  • 633.60K
  • shuangqing peng
  • Core technical personnel
  • 909.80K
  • yongmei xu
  • Core technical personnel
  • 792.00K
  • zhigang li
  • Core technical personnel
  • 892.60K
  • lei wang
  • Employee supervisors
  • 141.10K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg